Corrigendum to "Outcomes of concomitant antiobesity medication use with endoscopic sleeve gastroplasty in clinical US settings" [Obes. Pillars, Volume 11, September 2024, 100112]

Obes Pillars. 2024 Jun 29:11:100116. doi: 10.1016/j.obpill.2024.100116. eCollection 2024 Sep.

Affiliations

¹ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
² True You Weight Loss, Cary, NC, USA.
³ Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, USA.
⁴ Eviva, Shoreline, WA, USA.
⁵ Methodist Dallas Medical Center, Dallas, TX, USA.
⁶ NorthShore University Health System, Evanston, IL, USA.
⁷ University of Texas Health Science Center - Houston, Houston, TX, USA.

Abstract

[This corrects the article DOI: 10.1016/j.obpill.2024.100112.].

© 2024 The Author(s).

Publication types

Published Erratum